Darko Aleksovski1, Dragana Miljkovic1, Daniele Bravi2, Angelo Antonini3. 1. Department of Knowledge Technologies, Jozef Stefan Institute, Ljubljana, Slovenia. 2. Lundbeck Research and Development, Copenhagen, Denmark. 3. Department of Neuroscience, University of Padua, Padua, Italy. angelo3000@yahoo.com.
Abstract
INTRODUCTION: Discrete patterns of progression have been suggested for patients with Parkinson disease and presenting tremor dominant (TD) or postural instability gait disorders (PIGD). However, longitudinal prospective assessments need to take into consideration the variability in clinical manifestations and the evidence that only 40% of initially classified PIGD remain in this subtype at subsequent visits. METHODS: We analyzed clinical progression of PIGD compared to TD using longitudinal clinical data from the PPMI. Given the reported instability of such clinical classification, we only included patients who were reported as PIGD/TD at each visit during the 4-year observation. We used linear mixed-effects models to test differences in progression in these subgroups in 51 dependent variables. RESULTS: There were 254 patients with yearly assessment. The number of PIGD was 36/254 vs 144/254 TD. PIGD had more severe motor disease at baseline but progressed faster than TD only in three non-motor items of the MDS-UPDRS: cognitive impairment, hallucinations, and psychosis plus features of DDS. Our analysis also showed in PIGD faster increase in the average time with dyskinesia. CONCLUSIONS: PIGD are characterized by more severe disease manifestations at diagnosis and greater cognitive progression, more frequent hallucinations, psychosis as well as features of DDS than TD patients. We interpret these findings as expression of greater cortical and subcortical involvement in PIGD already at onset. Since PIGD/TD classification is very unstable at onset, our analysis based on stricter definition criteria provides important insight for clinical trial stratification and definition of related outcome measures.
INTRODUCTION: Discrete patterns of progression have been suggested for patients with Parkinson disease and presenting tremor dominant (TD) or postural instability gait disorders (PIGD). However, longitudinal prospective assessments need to take into consideration the variability in clinical manifestations and the evidence that only 40% of initially classified PIGD remain in this subtype at subsequent visits. METHODS: We analyzed clinical progression of PIGD compared to TD using longitudinal clinical data from the PPMI. Given the reported instability of such clinical classification, we only included patients who were reported as PIGD/TD at each visit during the 4-year observation. We used linear mixed-effects models to test differences in progression in these subgroups in 51 dependent variables. RESULTS: There were 254 patients with yearly assessment. The number of PIGD was 36/254 vs 144/254 TD. PIGD had more severe motor disease at baseline but progressed faster than TD only in three non-motor items of the MDS-UPDRS: cognitive impairment, hallucinations, and psychosis plus features of DDS. Our analysis also showed in PIGD faster increase in the average time with dyskinesia. CONCLUSIONS: PIGD are characterized by more severe disease manifestations at diagnosis and greater cognitive progression, more frequent hallucinations, psychosis as well as features of DDS than TD patients. We interpret these findings as expression of greater cortical and subcortical involvement in PIGD already at onset. Since PIGD/TD classification is very unstable at onset, our analysis based on stricter definition criteria provides important insight for clinical trial stratification and definition of related outcome measures.
Entities:
Keywords:
Cognition; Motor fluctuations; PIGD; PPMI; Parkinson disease; Progression; Tremor
Authors: V E Kelly; C O Johnson; E L McGough; A Shumway-Cook; F B Horak; K A Chung; A J Espay; F J Revilla; J Devoto; C Wood-Siverio; S A Factor; B Cholerton; K L Edwards; A L Peterson; J F Quinn; T J Montine; C P Zabetian; J B Leverenz Journal: Parkinsonism Relat Disord Date: 2015-04-14 Impact factor: 4.891
Authors: Stephanie M van Rooden; Fabrice Colas; Pablo Martínez-Martín; Martine Visser; Dagmar Verbaan; Johan Marinus; Ray K Chaudhuri; Joost N Kok; Jacobus J van Hilten Journal: Mov Disord Date: 2010-11-16 Impact factor: 10.338
Authors: Glenn T Stebbins; Christopher G Goetz; David J Burn; Joseph Jankovic; Tien K Khoo; Barbara C Tilley Journal: Mov Disord Date: 2013-02-13 Impact factor: 10.338
Authors: Mike A Nalls; Cory Y McLean; Jacqueline Rick; Shirley Eberly; Samantha J Hutten; Katrina Gwinn; Margaret Sutherland; Maria Martinez; Peter Heutink; Nigel M Williams; John Hardy; Thomas Gasser; Alexis Brice; T Ryan Price; Aude Nicolas; Margaux F Keller; Cliona Molony; J Raphael Gibbs; Alice Chen-Plotkin; Eunran Suh; Christopher Letson; Massimo S Fiandaca; Mark Mapstone; Howard J Federoff; Alastair J Noyce; Huw Morris; Vivianna M Van Deerlin; Daniel Weintraub; Cyrus Zabetian; Dena G Hernandez; Suzanne Lesage; Meghan Mullins; Emily Drabant Conley; Carrie A M Northover; Mark Frasier; Ken Marek; Aaron G Day-Williams; David J Stone; John P A Ioannidis; Andrew B Singleton Journal: Lancet Neurol Date: 2015-08-10 Impact factor: 44.182
Authors: Michela Russo; Marianna Amboni; Antonio Volzone; Gianluca Ricciardelli; Giuseppe Cesarelli; Alfonso Maria Ponsiglione; Paolo Barone; Maria Romano; Carlo Ricciardi Journal: Eur J Transl Myol Date: 2022-06-07
Authors: Nirosen Vijiaratnam; Michael Lawton; Amanda J Heslegrave; Tong Guo; Manuela Tan; Edwin Jabbari; Raquel Real; John Woodside; Katherine Grosset; Viorica Chelban; Dilan Athauda; Christine Girges; Roger A Barker; John Hardy; Nicholas Wood; Henry Houlden; Nigel Williams; Yoav Ben-Shlomo; Henrik Zetterberg; Donald G Grosset; Thomas Foltynie; Huw R Morris Journal: J Neurol Neurosurg Psychiatry Date: 2022-05-16 Impact factor: 13.654